Management of Elderly Patients with Glioblastoma.

about

Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials.Radiotherapy of Glioblastoma 15 Years after the Landmark Stupp’s Trial: More Controversies than Standards?

P2860

Q47161135-6245D67F-2C1F-4104-A32C-B9F33F7A9E6E Q55711736-7B768417-C683-42B6-9D58-31C73410A2B9

P2860

Management of Elderly Patients with Glioblastoma.

Item

http://www.wikidata.org/entity/Q39190627

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Management of Elderly Patients with Glioblastoma.

@en

Management of Elderly Patients with Glioblastoma.

@nl

type

Item

label

Management of Elderly Patients with Glioblastoma.

@en

Management of Elderly Patients with Glioblastoma.

@nl

prefLabel

Management of Elderly Patients with Glioblastoma.

@en

Management of Elderly Patients with Glioblastoma.

@nl

P1476

Management of Elderly Patients with Glioblastoma.

@en

P2093

Dorothee Gramatzki

http://www.w3.org/2001/XMLSchema#string

Patrick Roth

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Prospects of immune checkpoint modulators in the treatment of glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

A randomized trial of bevacizumab for newly diagnosed glioblastoma

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

P2888

s11910-017-0740-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11910-017-0740-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael Weller

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28324304

http://www.w3.org/2001/XMLSchema#string

Management of Elderly Patients with Glioblastoma.

about

P2860

P2860

Management of Elderly Patients with Glioblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698